Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetes
US7618951B2 · kind B2 · utility
3Cited by
6References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 12, 2003 |
| Grant date | Nov 17, 2009 |
| Priority date | — |
| Expiry date | Jun 22, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of prebiotics for the preparation of food or pharmaceutical compositions which are intended for the treatment and/or prevention of hyperglycaemic syndromes and, in particular, for the treatment of Type II diabetes and/or the prevention of the onset of Type II diabetes in patients with a predisposition to developing the type of diabetes. The invention also relates to the food and pharmaceutical compositions containing the prebiotics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.